PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD

Gordon Freeman, PhD. Professor of Medicine, Harvard Medical School
Host: Patrick Hogan
A fascinating look at what’s new in cancer immunology research and Dr. Freeman’s findings regarding B7-1 and B7-2 proteins. A closer look at advances in checkpoint inhibitor / blockage approaches. Seminar hosted by La Jolla Institute for Immunology in San Diego, CA. #STEM #STEMCareers #Cancer #Oncology #CancerTherapies #Immunotherapies
www.lji.org

[@titanium1983]

very useful and exciting lecture, i have learned a lot, thank you very much.